A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

Clinical trial NCT00322985 · COMPLETED

Trial details

NCT number: NCT00322985
Sponsor: AHS Cancer Control Alberta
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Lymphoma

Start date: 2006-06-01
Primary completion: 2014-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.